Therapeutic effect of autologous bone marrow-derived liver stem cells transplantation in hepatitis B virus-induced liver cirrhosis

Hepato-Gastroenterology

Volumn 60, Issue 123, 2013, Pages 406-409

  Liao, XinXin ^a   Yuan, Jie ^a   Qin, AnCheng ^a   Qin, ^a   Zhou, Jie ^a   Liao, CaiXian ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Autologous transplantation; Bone marrow; Liver cirrhosis; Stem cell

Indexed keywords

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW DERIVED STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEVASCULARIZATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; IN VITRO STUDY; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; PATIENT SAFETY; PORTAL HYPERTENSION; PRIORITY JOURNAL; SPLENECTOMY; STEM CELL EXPANSION; THERAPY EFFECT;

ADULT; BIOLOGICAL MARKERS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; FEMALE; HEPATIC ARTERY; HEPATITIS B, CHRONIC; HEPATOCYTES; HUMANS; HYPERTENSION, PORTAL; INFUSIONS, INTRA-ARTERIAL; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; SPLENECTOMY; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84879579946     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge.12821     Document Type: Article

References (27)

1. Lee Z, Dennis JE, Gerson SL: Imaging stem cell implant for cellular-based therapies. Exp Biol Med 2008; 233:930-940.
2. Petersen BE, Bowen WC, Patrene KD, et al.: Bone marrow as a potential source of hepatic oval cells. Science 1999; 284:1168-1170. (Pubitemid 29288406)
3. Theise ND, Badve S, Saxena R, et al.: Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. Hepatology 2000; 31:235-240. (Pubitemid 30033713)
4. Schwartz RE, Reyes M, Koodie L, et al.: Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002; 109:1291-1302. (Pubitemid 34546893)
5. Avital I, Feraresso C, Aoki T, et al.: Bone marrow-derived liver stem cell and mature hepatocyte engraftment in livers undergoing rejection. Surgery 2002; 132:384-390. (Pubitemid 35024789)
6. Sakaida I, Teral S, Yamamoto N, et al.: Transplantation of bone marrow cells reduces CC14-induced liver fibrosis in mice. Hepatology 2004; 40:1304-1311. (Pubitemid 39657004)
7. Lagasse E, Connors H, Al-Dhalimy M, et al.: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6:1229-1234.
8. Lorenti AS: Hepatic stem cells. Medicina (B Aires). 2001; 61:614-620. (in Spanish)
9. Liao CX, Tang H, Zhou J, et al.: Comparison of the hepatic stem cell potential of CD90+Lin-, CD34+Lin-, CD117+Lin- and Sca-1+Lin- bone marrow cells in mice. J Hepatol Surg 2006; 6:458-460 (in Chinese with English abstract).
10. Peled A, Petit I, Kollet O, et al.: Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999; 283:845-848.
11. Hatch HM, Zheng D, Jorgensen ML, et al.: SDF-1alpha/CXCR4: a mechanism for hepatic oval cell activation and bone marrow stem cell recruitment to the injured liver of rats. Cloning Stem Cells 2002; 4:339-351. (Pubitemid 36105802)
12. Majka M, Kucia M, Ratajczak MZ: Stem cell biology: a never ending quest for understanding. Acta Biochim Pol 2005; 52:353-358. (Pubitemid 41133770)
13. Yagi K, Kojima M, Oyagi S, et al.: Application of mesenchymal stem cells to liver regenerative medicine. Yakugaku Zasshi 2008; 128:3-9.
14. Zhang Y, Wen T, Yan L, et al.: The changes of hepatic hemodynamics and functional hepatic reserve after splenectomy with periesophagogastric devascularization. Hepatogastroenterology 2009; 56:835-839.
15. Yuan J, Liao CX, Qin AC, et al.: Protocols for cloning human bone marrow-derived hepatic stem cells in vitro. Nan Fang Yi Ke Da Xue Xue Bao 2010; 30:318-320 (in Chinese with English abstract).
16. Lu FM, Zhuang H: Management of hepatitis B in China. Chin Med J (Engl) 2009; 122:3-4.
17. Tang H, Liao CX, Zhou J, et al.: Differentiation of transplanted mouse c-Kit+lin- bone marrow cells into hepatocytes in vitro. Nan Fang Yi Ke Da Xue Xue Bao 2006; 26:567-569. (in Chinese with English abstract).
18. Terai S, Ishikawa T, Omori K, et al.: Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006; 24:2292-2298. (Pubitemid 44527483)
19. Cao BQ, Lin JZ, Zhong YS, et al.: Autologous bone marrow cells transplantation via portal vein for the treatment of cirrhotic patients with hepatic dysfunction. Chin J Gen Surg 2007; 22:386-389.
20. Wu YM, Joseph B, Berishvili E, et al.: Hepatocyte transplantation and drug-induced perturbations in liver cell compartments. Hepatology 2008; 47:279-287. (Pubitemid 351171065)
21. Huang YT: Characteristics of the surgical treatment of portal hypertension in China. Chin J Hepatobiliary Surg 2002; 8:3-4. (in Chinese)
22. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, et al.: Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007; 10:459-466. (Pubitemid 350001896)
23. Am EJN, Knoefel WT, Klein M, et al.: Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005; 23:463-470. (Pubitemid 40478484)
24. Nikeghbalian S, Pournasr B, Aghdami N, et al.: Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis. Arch Iran Med 2011; 14:12-17.
25. Mohamadnejad M, Namiri M, Bagheri M, et al.: Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 2007; 13:3359-3363. (Pubitemid 47062247)
26. Lyra AC, Soares MB, Da SL, et al.: Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol. 2007; 13:1067-1073. (Pubitemid 46511008)
27. Amer ME, El-Sayed SZ, El-Kheir WA, et al.: Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells. Eur J Gastroenterol Hepatol 2011; 23:936-941.